{"id":28497,"date":"2022-07-29T17:06:22","date_gmt":"2022-07-29T15:06:22","guid":{"rendered":"http:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-2\/"},"modified":"2022-09-12T18:29:35","modified_gmt":"2022-09-12T16:29:35","slug":"cytomegalovirus-cmv-antistoffen","status":"publish","type":"vademecum","link":"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/","title":{"rendered":"Cytomegalovirus (CMV)"},"content":{"rendered":"

Diagnostiek voor het aantonen van een primaire infectie bestaat uit het aantonen van de aanwezigheid van IgM en IgG antistoffen tegen CMV. IgM antistoffen ontstaan meestal in de eerste twee weken na het ontstaan van symptomen en kunnen enkele maanden persisteren. IgG antistoffen ontstaan vanaf twee tot drie weken na het ontstaat van de symptomen en persisteren levenslang. Voor het aantonen van een reactivatie van CMV bij immuungecomprimenteerden kan een PCR op EDTA verricht worden.<\/p>\n","protected":false},"excerpt":{"rendered":"

Diagnostiek voor het aantonen van een primaire infectie bestaat uit het aantonen van de aanwezigheid van IgM en IgG antistoffen tegen CMV. IgM antistoffen ontstaan meestal in de eerste twee <\/p>\n","protected":false},"featured_media":0,"template":"","categories":[54],"class_list":["post-28497","vademecum","type-vademecum","status-publish","hentry","category-medische-microbiologie"],"acf":[],"yoast_head":"\nCytomegalovirus (CMV) - Clinical Diagnostics Nederland<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cytomegalovirus (CMV) - Clinical Diagnostics Nederland\" \/>\n<meta property=\"og:description\" content=\"Diagnostiek voor het aantonen van een primaire infectie bestaat uit het aantonen van de aanwezigheid van IgM en IgG antistoffen tegen CMV. IgM antistoffen ontstaan meestal in de eerste twee\" \/>\n<meta property=\"og:url\" content=\"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/\" \/>\n<meta property=\"og:site_name\" content=\"Clinical Diagnostics Nederland\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Eurofins-Clinical-Diagnostics-107368791395214\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-12T16:29:35+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/\",\"url\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/\",\"name\":\"Cytomegalovirus (CMV) - Clinical Diagnostics Nederland\",\"isPartOf\":{\"@id\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/#website\"},\"datePublished\":\"2022-07-29T15:06:22+00:00\",\"dateModified\":\"2022-09-12T16:29:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cytomegalovirus (CMV)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/#website\",\"url\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/\",\"name\":\"Clinical Diagnostics Nederland\",\"description\":\"Clinical Diagnostics Nederland\",\"publisher\":{\"@id\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/#organization\",\"name\":\"Eurofins Clinical Diagnostics\",\"url\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/clinical.dev1.sowieso.biz\/wp-content\/uploads\/2021\/07\/logo-eurofins-clinical-diagnostics-rgb.svg\",\"contentUrl\":\"http:\/\/clinical.dev1.sowieso.biz\/wp-content\/uploads\/2021\/07\/logo-eurofins-clinical-diagnostics-rgb.svg\",\"width\":632,\"height\":135,\"caption\":\"Eurofins Clinical Diagnostics\"},\"image\":{\"@id\":\"https:\/\/clinical.dev1.sowieso.biz\/nl\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Eurofins-Clinical-Diagnostics-107368791395214\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cytomegalovirus (CMV) - Clinical Diagnostics Nederland","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/","og_locale":"nl_NL","og_type":"article","og_title":"Cytomegalovirus (CMV) - Clinical Diagnostics Nederland","og_description":"Diagnostiek voor het aantonen van een primaire infectie bestaat uit het aantonen van de aanwezigheid van IgM en IgG antistoffen tegen CMV. IgM antistoffen ontstaan meestal in de eerste twee","og_url":"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/","og_site_name":"Clinical Diagnostics Nederland","article_publisher":"https:\/\/www.facebook.com\/Eurofins-Clinical-Diagnostics-107368791395214","article_modified_time":"2022-09-12T16:29:35+00:00","twitter_card":"summary_large_image","twitter_misc":{"Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/","url":"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/","name":"Cytomegalovirus (CMV) - Clinical Diagnostics Nederland","isPartOf":{"@id":"https:\/\/clinical.dev1.sowieso.biz\/nl\/#website"},"datePublished":"2022-07-29T15:06:22+00:00","dateModified":"2022-09-12T16:29:35+00:00","breadcrumb":{"@id":"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/clinical.dev1.sowieso.biz\/nl\/vademecum\/cytomegalovirus-cmv-antistoffen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/clinical.dev1.sowieso.biz\/nl\/"},{"@type":"ListItem","position":2,"name":"Cytomegalovirus (CMV)"}]},{"@type":"WebSite","@id":"https:\/\/clinical.dev1.sowieso.biz\/nl\/#website","url":"https:\/\/clinical.dev1.sowieso.biz\/nl\/","name":"Clinical Diagnostics Nederland","description":"Clinical Diagnostics Nederland","publisher":{"@id":"https:\/\/clinical.dev1.sowieso.biz\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/clinical.dev1.sowieso.biz\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/clinical.dev1.sowieso.biz\/nl\/#organization","name":"Eurofins Clinical Diagnostics","url":"https:\/\/clinical.dev1.sowieso.biz\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/clinical.dev1.sowieso.biz\/nl\/#\/schema\/logo\/image\/","url":"http:\/\/clinical.dev1.sowieso.biz\/wp-content\/uploads\/2021\/07\/logo-eurofins-clinical-diagnostics-rgb.svg","contentUrl":"http:\/\/clinical.dev1.sowieso.biz\/wp-content\/uploads\/2021\/07\/logo-eurofins-clinical-diagnostics-rgb.svg","width":632,"height":135,"caption":"Eurofins Clinical Diagnostics"},"image":{"@id":"https:\/\/clinical.dev1.sowieso.biz\/nl\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Eurofins-Clinical-Diagnostics-107368791395214"]}]}},"_links":{"self":[{"href":"https:\/\/clinical.dev1.sowieso.biz\/nl\/wp-json\/wp\/v2\/vademecum\/28497","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinical.dev1.sowieso.biz\/nl\/wp-json\/wp\/v2\/vademecum"}],"about":[{"href":"https:\/\/clinical.dev1.sowieso.biz\/nl\/wp-json\/wp\/v2\/types\/vademecum"}],"wp:attachment":[{"href":"https:\/\/clinical.dev1.sowieso.biz\/nl\/wp-json\/wp\/v2\/media?parent=28497"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinical.dev1.sowieso.biz\/nl\/wp-json\/wp\/v2\/categories?post=28497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}